Therapeutic effect of mizoribine on bullous pemphigoid associated with membranous nephropathy.
暂无分享,去创建一个
[1] S. Kohno,et al. Changing mizoribine administration from three divided doses to one single dose induced remission of relapsed membranous nephropathy. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[2] M. Akiyama,et al. Correlation of clinical severity and ELISA indices for the NC16A domain of BP180 measured using BP180 ELISA kit in bullous pemphigoid. , 2005, Journal of dermatological science.
[3] N. Yorioka,et al. A randomized open-label comparative study of conventional therapy versus mizoribine onlay therapy in patients with steroid-resistant nephrotic syndrome (postmarketing survey) , 2004, Journal of Clinical and Experimental Nephrology.
[4] T. Nishikawa,et al. BP180 ELISA using bacterial recombinant NC16a protein as a diagnostic and monitoring tool for bullous pemphigoid. , 2002, Journal of dermatological science.
[5] J. Gustafsson,et al. Functional interaction of the immunosuppressant mizoribine with the 14-3-3 protein. , 2000, Biochemical and biophysical research communications.